Benchling
Latest round
- Series F
Last raised
- Oct 2021
Total raised
- $418M
Investors
- 20
About Benchling
Founded in 2012 in San Francisco, CA, Benchling, Inc. operates as a biotechnology software company, providing cloud-based solutions that facilitate research and development for scientists across various fields. Benchling, Inc.66 billion. Benchling offers a comprehensive suite of cloud-based solutions tailored for the biotechnology research and development sector. The company's core products include Benchling Bioresearch, Benchling Bioprocess, and Benchling In Vivo, enabling scientists to plan, record, and share experiments seamlessly through an integrated electronic lab notebook (ELN). These solutions automate workflows, capture scientific data efficiently, and facilitate collaboration. Leveraging artificial intelligence, Benchling enhances productivity and accelerates data analysis across applications, including biomolecular research and gene therapy. Over 200,000 scientists, including startups and prominent biopharmaceutical companies in North America, Europe, and Asia, utilize Benchling’s platforms for research efficiency. Benchling's revenue model is primarily based on subscription services, where customers access its suite of products through tiered pricing plans. Clients typically engage in annual subscriptions that vary based on their operational scale and required tools, including features from Benchling Bioresearch and Benchling Insights. The company also provides customer success packages for tailored support, enhancing the user experience. Benchling's partnerships with leading biopharmaceutical firms and research institutions reinforce its market reputation, facilitating robust B2B relationships and long-term collaborations that adapt its capabilities to clients' evolving scientific needs. The company aims to introduce new products designed to enhance its offerings for biotechnology research.
Who invested in Benchling
20 investors across 7 rounds
See all investors in Benchling
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
Oct 20, 2021
Amount
$105M
Investors
Series E
Mar 12, 2021
Amount
$200M
Investors
Series D
Mar 24, 2020
Amount
$51M
Investors
Series C
Apr 16, 2019
Amount
$35M
Investors
Series B
Mar 23, 2018
Amount
$16M
Investors
Series A
Apr 18, 2016
Amount
$7M
Investors
Seed
Feb 6, 2015
Amount
$5.1M
Investors
Questions about Benchling
Who invested in Benchling?
Benchling has 20 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Benchling raised?
Benchling has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Benchling last raise money?
Benchling's most recent round on record is a Series F, in Oct 2021.
What does Benchling do?
Founded in 2012 in San Francisco, CA, Benchling, Inc.
Where is Benchling headquartered?
Benchling is headquartered in San Francisco, US.
Which VCs invest in companies like Benchling?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Benchling's stage. Their profiles are linked below.
VCs backing software startups at Series F
Raising like Benchling? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.